<DOC>
	<DOCNO>NCT00070291</DOCNO>
	<brief_summary>RATIONALE : Cyclosporine may help immune system slow growth angioimmunoblastic T-cell lymphoma . PURPOSE : This phase II trial study well cyclosporine work treat patient recurrent refractory angioimmunoblastic T-cell lymphoma .</brief_summary>
	<brief_title>Cyclosporine Treating Patients With Recurrent Refractory Angioimmunoblastic T-Cell Lymphoma</brief_title>
	<detailed_description>OBJECTIVES : Primary - Determine response rate ( complete partial ) patient recurrent refractory angioimmunoblastic T-cell lymphoma treat cyclosporine . Secondary - Determine disease-free , progression-free , overall survival patient treated drug . - Determine toxicity drug patient . OUTLINE : Patients receive oral cyclosporine twice daily 36 week absence unacceptable toxicity disease progression week 1-6 . Patients experience disease progression week 7-36 , receive additional 36 week therapy . Patients follow every 3 month 2 year every 6 month 1 year . PROJECTED ACCRUAL : A total 27 patient accrue study within 2.5 year .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , T-Cell</mesh_term>
	<mesh_term>Immunoblastic Lymphadenopathy</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<criteria>Diagnosis angioimmunoblastic Tcell lymphoma ( recurrent refractory ) base histologic examination . At least one objective measurable evaluable disease parameter . Have fail least one type treatment : chemotherapy , autotransplant , steroid treatment . Patients may receive concurrent chemotherapy . Eastern Cooperative Oncology Group ( ECOG ) performance status 02 . Adequate renal function indicate creatinine &lt; = 1.5 upper limit normal ( ULN ) . Adequate liver function indicate alkaline phosphatase , Aspartate Aminotransferase ( AST ) , Alanine Aminotransferase ( ALT ) &lt; = 2x upper limit normal . Total bilirubin &lt; = 2x upper limit normal . Age 18 old . Prior cyclosporine Tacrolimus ( FK506 ) . Prior allogeneic transplant . Evidence active infection . Congestive heart failure , kidney failure , liver failure , severe comorbidities . Evidence active neurological impairment . Previous history hypersensitivity cyclosporine and/or Cremorphor EL ( polyoxyethylated oil ) . History malignancy ( cure carcinoma situ cervix basal cell carcinoma skin ) . pregnant breastfeed woman . Human immunodeficiency virus ( HIV ) positive .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>angioimmunoblastic T-cell lymphoma</keyword>
</DOC>